MEG3 rs7158663 genetic polymorphism is associated with the risk of hepatocellular carcinoma

References

• Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2018, 68, 394–424. DOI: 10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Chuang, S. C.; La Vecchia, C.; Boffetta, P. Liver Cancer: Descriptive Epidemiology and Risk Factors Other than HBV and HCV Infection. Cancer Lett. 2009, 286, 9–14. DOI: 10.1016/j.canlet.2008.10.040.
   PubMed Web of Science ®Google Scholar
• Yin, G.; Kong, W.; Liu, X.; Zheng, S.; Ying, R.; Shan, Y. Association of RASSF1A Ala133Ser Polymorphism with Cancer Risk: A Updated Meta-Analysis Involving 7362 Subjects. Nucleosides Nucleotides Nucleic Acids 2022, 41, 1084–1098.
   PubMed Web of Science ®Google Scholar
• Zhang, S.; Chen, L.; Wang, Y.; Tang, W.; Chen, Y.; Liu, L. Investigation of the Association of miRNA-499, miRNA-146a, miRNA-196a2 Loci with Hepatocellular Carcinoma Risk: A Case-Control Study Involving 1507 Subjects. DNA Cell Biol. 2020, 39, 379–388. DOI: 10.1089/dna.2019.5145.
   PubMed Web of Science ®Google Scholar
• Zhou, Y.; Zhang, X.; Klibanski, A. MEG3 Noncoding RNA: A Tumor Suppressor. J. Mol. Endocrinol. 2012, 48, R45–53. DOI: 10.1530/JME-12-0008.
   PubMed Web of Science ®Google Scholar
• Zhu, J.; Liu, S.; Ye, F.; Shen, Y.; Tie, Y.; Zhu, J.; Wei, L.; Jin, Y.; Fu, H.; Wu, Y.; et al. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells. PLoS One. 2015, 10, e0139790. DOI: 10.1371/journal.pone.0139790.
   PubMed Web of Science ®Google Scholar
• He, J. H.; Han, Z. P.; Liu, J. M.; Zhou, J. B.; Zou, M. X.; Lv, Y. B.; Li, Y. G.; Cao, M. R. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664. J. Cell. Biochem. 2017, 118, 3713–3721. DOI: 10.1002/jcb.26018.
   PubMed Web of Science ®Google Scholar
• Liu, Z.; Chen, J. Y.; Zhong, Y.; Xie, L.; Li, J. S. lncRNA MEG3 Inhibits the Growth of Hepatocellular Carcinoma Cells by Sponging miR-9-5p to Upregulate SOX11. Braz. J. Med. Biol. Res. 2019, 52, e8631. DOI: 10.1590/1414-431X20198631.
   PubMed Web of Science ®Google Scholar
• Sun, Q.; Chong, F.; Jiang, X.; Wang, Y.; Xu, K.; Zou, Y.; Song, C. Association Study of SNPs in LncRNA CDKN2B-AS1 with Breast Cancer Susceptibility in Chinese Han Population. Int. J. Biochem. Cell Biol. 2022, 143, 106139. DOI: 10.1016/j.biocel.2021.106139.
   PubMed Web of Science ®Google Scholar
• Li, L.; Huang, Q.; Yan, F.; Wei, W.; Li, Z.; Liu, L.; Deng, J. Association between Long Non-Coding RNA H19 Polymorphisms and Breast Cancer Risk: A Meta-Analysis. Women Health. 2022, 62, 565–575. DOI: 10.1080/03630242.2022.2096748.
   PubMed Web of Science ®Google Scholar
• Cao, L.; Yan, G.; Yu, S.; Li, F.; Su, Z.; Hou, X.; Xiao, J.; Tian, T. Associations of MALAT1 and Its Functional Single Nucleotide Polymorphisms with Cancer. Pathol. Res. Pract. 2022, 236, 153988. DOI: 10.1016/j.prp.2022.153988.
   PubMed Web of Science ®Google Scholar
• Gao, X.; Li, X.; Zhang, S.; Wang, X. The Association of MEG3 Gene rs7158663 Polymorphism with Cancer Susceptibility. Front. Oncol. 2021, 11, 796774. DOI: 10.3389/fonc.2021.796774.
   PubMed Web of Science ®Google Scholar
• Mohammed, S. R.; Shaker, O. G.; Mohamed, M. M.; Abdelhafez Mostafa, M. N.; Gaber, S. N.; Ali, D. Y.; Hussein, H. A.; Elebiary, A.; M.; Abonar, A. A.; Eid, H. M.; et al. The Emerging Role of lncRNA MEG3 and MEG3 rs7158663 in Hepatocellular Carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 11–21.
   PubMed Web of Science ®Google Scholar
• Quan, C.; Ping, J.; Lu, H.; Zhou, G.; Lu, Y. 3DSNP 2.0: Update and Expansion of the Noncoding Genomic Variant Annotation Database. Nucleic Acids Res. 2022, 50, D950–D955. DOI: 10.1093/nar/gkab1008.
   PubMed Web of Science ®Google Scholar
• Kong, X.; Yang, S.; Liu, C.; Tang, H.; Chen, Y.; Zhang, X.; Zhou, Y.; Liang, G. Relationship between MEG3 Gene Polymorphism and Risk of Gastric Cancer in Chinese Population with High Incidence of Gastric Cancer. Biosci. Rep. 2020, 40, BSR20200305.
   PubMed Web of Science ®Google Scholar
• Zhang, Q.; Ai, L.; Dai, Y. G. Association between Polymorphism of Long Non Coding RNA Maternally Expressed Gene 3 and Risk of Gastric Cancer. Chin. J. Bases Clinics Gen. Surg. 2018, 25, 1323–1326.
   Google Scholar
• Cao, X.; Zhuang, S.; Hu, Y.; Xi, L.; Deng, L.; Sheng, H.; Shen, W. Associations between Polymorphisms of Long Non-Coding RNA MEG3 and Risk of Colorectal Cancer in Chinese. Oncotarget 2016, 7, 19054–19059. DOI: 10.18632/oncotarget.7764.
   PubMedGoogle Scholar
• Huang, J.; Zhang, X.; Zhang, M.; Zhu, J. D.; Zhang, Y. L.; Lin, Y.; Wang, K. S.; Qi, X. F.; Zhang, Q.; Liu, G. Z.; et al. Up-Regulation of DLK1 as an Imprinted Gene Could Contribute to Human Hepatocellular Carcinoma. Carcinogenesis 2007, 28, 1094–1103. DOI: 10.1093/carcin/bgl215.
   PubMed Web of Science ®Google Scholar
• Lou, J.; Yan, W.; Li, Q. Y.; Zhu, A. K.; Tan, B. Q.; Dong, R.; Zou, X. Z.; Liu, T. LncRNA MEG8 Plays an Oncogenic Role in Hepatocellular Carcinoma Progression through miR-367-3p/14-3-3ζ/TGFβR1 Axis. Neoplasma 2021, 68, 273–282. DOI: 10.4149/neo_2020_200730N785.
   PubMed Web of Science ®Google Scholar
• Zhou, J.; Lu, S.; Yang, S.; Chen, H.; Shi, H.; Miao, M.; Jiao, B. MicroRNA-127 Post-Transcriptionally Downregulates Sept7 and Suppresses Cell Growth in Hepatocellular Carcinoma Cells. Cell. Physiol. Biochem. 2014, 33, 1537–1546. DOI: 10.1159/000358717.
   PubMedGoogle Scholar
• Jia, H.; Wang, H.; Yao, Y.; Wang, C.; Li, P. miR-136 Inhibits Malignant Progression of Hepatocellular Carcinoma Cells by Targeting Cyclooxygenase 2. Oncol. Res. 2018, 26, 967–976. DOI: 10.3727/096504018X15148192843443.
   PubMed Web of Science ®Google Scholar
• Li, Y. W.; Wang, J. X.; Yin, X.; Qiu, S. J.; Wu, H.; Liao, R.; Yi, Y.; Xiao, Y. S.; Zhou, J.; Zhang, B. H.; et al. Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 in Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma. PLoS One. 2014, 9, e87505. DOI: 10.1371/journal.pone.0087505.
   PubMedGoogle Scholar
• Li, W.; Liang, Y.; Yang, B.; Sun, H.; Wu, W. Downregulation of ARNT2 Promotes Tumor Growth and Predicts Poor Prognosis in Human Hepatocellular Carcinoma. J. Gastroenterol. Hepatol. 2015, 30, 1085–1093. DOI: 10.1111/jgh.12905.
   PubMed Web of Science ®Google Scholar